4 Results for "

Setogepram

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Setogepram" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-100775A
CAS No.: 1002101-19-0
Purity:  99.38%
Synonyms: Setogepram; PBI-4050
Fezagepras (Setogepram) acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84 . Fezagepras decreases renal, liver and pancreatic fibrosis . Fezagepras exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100775
CAS No.: 1254472-97-3
Purity:  99.78%
Synonyms: Setogepram sodium; PBI-4050 sodium
Fezagepras (Setogepram) sodium acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84 . Fezagepras sodium decreases renal, liver and pancreatic fibrosis . Fezagepras sodium exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions .
loading...
    loading...
Cat. No.: HY-100775AR
CAS No.: 1002101-19-0
Synonyms: Setogepram (Standard); PBI-4050 (Standard)
Fezagepras (Standard) is the analytical standard of Fezagepras. This product is intended for research and analytical applications. Fezagepras (Setogepram) acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84 . Fezagepras decreases renal, liver and pancreatic fibrosis . Fezagepras exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions .
loading...
    loading...
Cat. No.: HY-100775R
CAS No.: 1254472-97-3
Synonyms: Setogepram sodium (Standard); PBI-4050 sodium (Standard)
Fezagepras (sodium) (Standard) is the analytical standard of Fezagepras (sodium). This product is intended for research and analytical applications. Fezagepras (Setogepram) sodium acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84 . Fezagepras sodium decreases renal, liver and pancreatic fibrosis . Fezagepras sodium exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions .
loading...
    loading...